Kedudukan dalam Saham
#18604
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Harga Saham
$0.88044964
Disegerakkan terakhir: 2026-07-31
Perubahan (1 hari)
-0.71%
Perubahan (1 tahun)
1,362.12%
Perdagangan Circio Holding ASA (CRNA)
Harga CRNA dengan permodalan pasaran b
Modal pasaran bagi Circio Holding ASA(CRNA)
Modal Pasaran: $192.54M
Sehingga August 2026, Circio Holding ASA mempunyai modal pasaran sebanyak $192.54M. Ini menjadikan Circio Holding ASA syarikat ke-18604th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Circio Holding ASA dari 2016 hingga 2026
CRNA berbanding dengan 5 teratas yang paling popular stocks
| Harga CRNA |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.088T
|
+2,642,458.94%
|
|
|
|
|
$4.629T
|
+2,404,177.67%
|
|
|
|
|
$4.108T
|
+2,133,786.54%
|
|
|
|
|
$3.687T
|
+1,914,721.92%
|
|
|
|
|
$2.800T
|
+1,453,992.01%
|
